Report for Sagi Y

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity - Weinreb_2008_Chem.Biol.Interact_175_318
Author(s) : Weinreb O , Bar-Am O , Amit T , Drigues N , Sagi Y , Youdim MB
Ref : Chemico-Biological Interactions , 175 :318 , 2008
Abstract : Weinreb_2008_Chem.Biol.Interact_175_318
ESTHER : Weinreb_2008_Chem.Biol.Interact_175_318
PubMedSearch : Weinreb_2008_Chem.Biol.Interact_175_318
PubMedID: 18598687

Title : The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats - Sagi_2005_Br.J.Pharmacol_146_553
Author(s) : Sagi Y , Drigues N , Youdim MB
Ref : British Journal of Pharmacology , 146 :553 , 2005
Abstract : Sagi_2005_Br.J.Pharmacol_146_553
ESTHER : Sagi_2005_Br.J.Pharmacol_146_553
PubMedSearch : Sagi_2005_Br.J.Pharmacol_146_553
PubMedID: 16086033

Title : Poster (57) A novel neuroprotective trifunctional cholinesterase inhibitor derivative of the antiparkinson drug, rasagiline, for treatment of dementia and lewy body disease co-morbid with depression -
Author(s) : Youdim MB , Sagi Y , Derigus N , Naoi M , Maruyama W , Amit T , Falash-Yogev M , Weinstock M
Ref : In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects , (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina :351 , 2004
PubMedID:

Title : Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo - Bar-Am_2004_J.Neurochem_89_1119
Author(s) : Bar-Am O , Yogev-Falach M , Amit T , Sagi Y , Youdim MB
Ref : Journal of Neurochemistry , 89 :1119 , 2004
Abstract : Bar-Am_2004_J.Neurochem_89_1119
ESTHER : Bar-Am_2004_J.Neurochem_89_1119
PubMedSearch : Bar-Am_2004_J.Neurochem_89_1119
PubMedID: 15147504

Title : Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor - Sagi_2003_J.Neurochem_86_290
Author(s) : Sagi Y , Weinstock M , Youdim MB
Ref : Journal of Neurochemistry , 86 :290 , 2003
Abstract : Sagi_2003_J.Neurochem_86_290
ESTHER : Sagi_2003_J.Neurochem_86_290
PubMedSearch : Sagi_2003_J.Neurochem_86_290
PubMedID: 12871570

Title : A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease - Weinstock_2003_Prog.Neuropsychopharmacol.Biol.Psychiatry_27_555
Author(s) : Weinstock M , Gorodetsky E , Poltyrev T , Gross A , Sagi Y , Youdim MB
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 27 :555 , 2003
Abstract : Weinstock_2003_Prog.Neuropsychopharmacol.Biol.Psychiatry_27_555
ESTHER : Weinstock_2003_Prog.Neuropsychopharmacol.Biol.Psychiatry_27_555
PubMedSearch : Weinstock_2003_Prog.Neuropsychopharmacol.Biol.Psychiatry_27_555
PubMedID: 12787840